Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits

Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits

Submitted by admin on April 15, 2024 - 11:00am
Source: 
Fierce Biotech
News Tags: 
Neumora Therapeutics
schizophrenia
FDA
clinical trials
NMRA-266
Headline: 
Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits
snippet: 

The FDA has placed a phase 1 trial of Neumora Therapeutics’ schizophrenia therapy on hold after preclinical data revealed rabbits dosed with the drug had experienced convulsions.

Do Not Allow Advertisers to Use My Personal information